Added sugar consumption is associated with adverse health outcomes, including weight gain and cardiometabolic disease, yet the reliance on self-reported methods to determine added sugar intake continues to be a significant research limitation. The purpose of this review is to summarize recent advances in the development of two potential predictive biomarkers of added sugar intake: d 13 C and urinary sugar excretion.
INTRODUCTION
A large body of evidence has associated added sugars consumption with adverse health outcomes, including metabolic and cardiovascular diseases [1] [2] [3] , weight gain [4, 5] , and poor diet quality [6] . The WHO recommends that 'free' sugars (i.e., added sugar and sugars naturally present in honey, syrups, and fruit juices) be limited to less than 10% of total energy intake, and ideally to less than 5% [7] , which is similar to the 10% or less added sugar intake recommendation in the USA [8] . Yet, current added sugar consumption patterns typically exceed these levels. For example, mean added sugar intake in the USA is 13% of total energy intake [9] , and ranges from 7 to 17% in European populations [7] . Intake levels among children tend to be even higherrepresenting 16% of total energy among children in the USA [10] , and 12-25% in Europe [7] .
Aside from intake recommendations, significant controversy exists surrounding the health effects of added sugar [2, 11, 12] , due in part to the methodological limitation of utilizing self-reported dietary intake assessment techniques [12, 13] . Underreporting is a particular problem for total energy intake and for socially undesirable foods, such as those containing added sugar [e.g., sweets, sugar-sweetened beverages (SSB)] [13, 14] . The availability of an objective marker of dietary added sugar intake could overcome this research limitation [13, 14] , strengthen the evidence base for intake recommendations, and significantly advance research addressing the health consequences of added sugar consumption.
The review will describe recent advances in the development of two biomarkers of added sugar intake: d 13 C in human tissues, which has been proposed as a predictive biomarker of corn and cane sugar intake, and urinary sugar excretion, which is a predictive biomarker of dietary sucrose and fructose intake.
Corn and cane plants utilize the phosphoenolpyruvate-carboxylase enzyme to preconcentrate CO 2 prior to carbon fixation, a process known as 'C 4 photosynthesis', and thus manufacture sugars naturally enriched in the heavy stable isotope of carbon ( 13 C) [15 & ]. As digested food is absorbed from the intestines into the bloodstream, the carbon within food becomes carbon within tissues. Thus, a high ratio of 13 C : 12 C (measured as 'd 13 C') in human blood may reflect a high ratio of 13 C : 12 C in the diet, with corn and cane sugars as important contributors (Fig. 1) Specimen types reflect different time periods of added sugar intake (e.g., blood glucose reflects acute added sugar consumption, whole blood reflects consumption over 2-3 weeks; hair reflects consumption over 2-4 months) [15 & ]. Prior to isotopic analysis, samples are quantitatively combusted to CO 2 (e.g., blood, nail, and hair tissues) or separated from mixture using gas and/or liquid chromatography (e.g., blood lipids, blood glucose). Samples are then assessed for 13/12 C 16 O 2 and 15/14 N 2 using natural abundance stable isotope MS. This technique requires minimal staff training for sample collection and storage for most sample types, no special storage or shipping conditions after collection, and can be performed on minimally invasive specimens (e.g., fingerstick blood, hair, and nails).
KEY POINTS
Controversy exists surrounding the health effects of added sugar intake, due in part to the well recognized limitations of self-reported dietary assessment methods.
In recent years, two approaches to objectively assess added sugar intake have received the most attentionthe carbon isotope biomarker d 13 C, and the urinary sugars excretion biomarker.
Most studies evaluating the d 13 C biomarker have been cross-sectional; only one short-term-controlled feeding study has been conducted to date. Dose-response associations between actual sugar intake and urinary sugar excretion have been reported, although individual variability is substantial at the same level of sugar intake.
Controlled feeding studies are needed to understand what individual characteristics and conditions impact biomarker values (e.g., age, disease states); the validity, reliability, and sensitivity of biomarker values should be compared using a variety of sample types and analytical approaches. 
Strengths and limitations
Advantages of this approach include the ability to use a wide variety of sample types -some which are minimally invasive -and the ease of sample collection, processing, and storage. Disadvantages include the potential confounding effects of nonsweetener corn and meat consumption which may or may not be an issue depending upon the study population [19, 20] , an inability to reflect all dietary sources of added sugar (e.g., beet sugar), the potential impact of additives or preservatives to samples such as blood or urine [15 ,21 && ], and analytical equipment requirements. However, analytical challenges may be more feasible in the future with the availability of an easily operable instrument that will be within the financial reach of most hospitals. Approaches which may be less sensitive but more feasibly implemented in large-scale, community-based trials (e.g., fingerstick blood) may be more better suited to studies in which categorizing added sugar intake levels is of interest. Therefore, the d 13 C biomarker approach has the potential for widespread application -ranging from clinical and field-based nutrition research to clinical practice.
Future research needs
The most pressing research need for this potential marker of sugar intake is a large-scale validation study, greater than 2-3 weeks in duration, using a controlled feeding design. A study with this design is also needed to evaluate the biomarker's sensitivity to detect changes in added sugar intake over time. Study samples should include more diverse populations in terms of geography, race/ethnicity, and age, as variations in nonsweetener corn/meat consumption patterns, regional agricultural practices, and tissue turnover times may differ according to stage of growth [ 
URINARY SUGAR EXCRETION: TOTAL SUGAR INTAKE BIOMARKER
When the disaccharide sucrose is consumed, most is broken down to glucose and fructose and absorbed in the small intestine. However, small amounts (i.e., milligram quantities or $0.05% of intake) of intact sucrose are also absorbed in the small intestine and, along with fructose, excreted in the urine [29 && ]. This observation suggested that urinary sucrose and fructose excretion could represent a biomarker of recent sugar intake, although both added sugar and naturally occurring sources of sugar (i.e., fructose from fruit/fruit juices) are reflected by the urinary sugar excretion measurement. To evaluate urinary sugar excretion, two or more 24-h urine samples are collected per participant. A preservative (e.g., thymol, boric acid) should be added to the collection container to prevent degradation of the excreted urinary sugars. Sample processing is minimal. Several analytical approaches can be used, including a commercially available assay kit and a spectrophotometer. To verify the completeness of 24-h urine collections, para-aminobenzoic acid (PABA) may be administered to participants prior to sample collection in tablet form or added into study foods. PABA excretion is assessed in urine samples using a colorimetric analysis [30] , and urine samples with at least 85% PABA recovery are generally considered complete and acceptable for inclusion in biomarker analyses [30] . Spot urine samples have also been evaluated for urinary sugar excretion [29
Recent human studies 
Strengths and limitations
Advantages of this technique include the use of a minimally invasive sample type, minimal sample processing requirements, the availability of a commercially available assay kit for urinary sugar analysis, the possibility of performing assessments in spot urine samples, and the ability to be used in populations which consume a greater variety of sugar sources (e.g., beet sugar). However, limitations include the short-time period reflected by this sugar biomarker (e.g., several hours to 1 day), which is not ideal for determining diet/disease associations as intake can vary over time, and the assessment of total sugar intake rather than added sugar, the latter of which is primarily targeted by dietary intake recommendations. Two or more 24-h urine collections per participant are needed at each assessment Case-cohort study, longitudinal point, which is burdensome for participants. Therefore compliance can be problematic, and should be assessed to insure that samples are complete, although possibly selectively [33] . Dose-response associations between sugar intake and biomarker values have been reported, yet there is substantial within-subject variability in sugar excretion at the same level of sugar intake [29
&&
]. Results can be impacted by numerous factor such as differences in intestinal permeability, which can vary with gastrointestinal disorders, infections, NSAIDs, and alcohol usage [29 && ].
Future research needs
Literature dating back several decades is available on the urinary sugar excretion marker of sugar intake, much more than on the carbon isotope sugar biomarker method in modern populations. Data are also available from several large-scale epidemiological trials, and at least two controlled feeding studies [30, 34] . Several studies had more of an emphasis on developing and utilizing calibration equations from biomarker values to predict sugar intake. 
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